Pancreatic stent does not provided added advantage over rectal NSAID for prevention of post-ERCP pancreatitis: First ever RCT
DOI: 10.1097/MPA.0000000000002090 Consecutive 321 patients with native papilla, were randomly assigned to Pancreatic stent, 50mg rectal diclofenac or stent + diclofenac at a single centre in Japan from 2014 to 2019. Pancreaitc injection performed in nearly half of all patients! 75% of all patients were considered high risk (either F<40, difficult cannulation, pancreatic cannulation, pancreatic injection, pre-cut, pancreatic sphincteortomy, balloon sphincteroplasty, IDUS, choledochoscopy) Procedure time was >30 mins in half of all patients. 5 patients in total developed pancreatitis (all mild), with no difference in any of the 3 sub-groups.